Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Forschner

Showing results (41-50 of 157) with videos related to

Pageof 16
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2021
Gibt es eine Überbehandlung von Melanompatienten am Ende ihres Lebens? Ergebnisse einer multizentrischen Studie an 193 MelanompatientenAndrea Forschner, Carmen Loquai, Frank Meiss, et al.
Cell Death & Disease|September 13, 2018
Melanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugsElena Makino, Vanessa Gutmann, Corinna Kosnopfel, et al.
Frontiers in Oncology|May 19, 2023
Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case reportSelina Reiter, Christopher Schroeder, Julian Broche, et al.
Therapeutic Advances in Medical Oncology|April 2, 2025
Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2Markus Reitmajer, Lena Nanz, Nina Müller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 25, 2025
Psychosocial distress and persistent adverse events in long-term survivors of stage IV melanoma - a cross-sectional questionnaire studyMarkus Reitmajer, Norbert Schäffeler, Anne Bach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2008
[G-DRG Version 2008: Facts and analyses]Marcel L Müller, Andrea Forschner, Andreas Wenke, et al.
Clinics in Dermatology|June 15, 2010
Melanoma staging: facts and controversiesAndrea Forschner, Thomas Kurt Eigentler, Annette Pflugfelder, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 21, 2019
Simultaneous targeted therapy for metastatic melanoma and hepatitis CLukas Kofler, Christoph Berg, Katrin Kofler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 28, 2020
Lukas Kofler, Christoph Berg, Katrin Kofler, et al.
Medicine|September 15, 2017
The need for psycho-oncological support for melanoma patients: Central role of patients' self-evaluationSimone Mayer, Martin Teufel, Norbert Schaeffeler, et al.
Pageof 16

Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2021
Gibt es eine Überbehandlung von Melanompatienten am Ende ihres Lebens? Ergebnisse einer multizentrischen Studie an 193 MelanompatientenAndrea Forschner, Carmen Loquai, Frank Meiss, et al.
Cell Death & Disease|September 13, 2018
Melanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugsElena Makino, Vanessa Gutmann, Corinna Kosnopfel, et al.
Frontiers in Oncology|May 19, 2023
Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case reportSelina Reiter, Christopher Schroeder, Julian Broche, et al.
Therapeutic Advances in Medical Oncology|April 2, 2025
Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2Markus Reitmajer, Lena Nanz, Nina Müller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 25, 2025
Psychosocial distress and persistent adverse events in long-term survivors of stage IV melanoma - a cross-sectional questionnaire studyMarkus Reitmajer, Norbert Schäffeler, Anne Bach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2008
[G-DRG Version 2008: Facts and analyses]Marcel L Müller, Andrea Forschner, Andreas Wenke, et al.
Clinics in Dermatology|June 15, 2010
Melanoma staging: facts and controversiesAndrea Forschner, Thomas Kurt Eigentler, Annette Pflugfelder, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 21, 2019
Simultaneous targeted therapy for metastatic melanoma and hepatitis CLukas Kofler, Christoph Berg, Katrin Kofler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 28, 2020
Lukas Kofler, Christoph Berg, Katrin Kofler, et al.
Medicine|September 15, 2017
The need for psycho-oncological support for melanoma patients: Central role of patients' self-evaluationSimone Mayer, Martin Teufel, Norbert Schaeffeler, et al.
Pageof 16